Go Pro
→ Free Stock Pick: The Company First in Line for America’s New Super Fuel (From Banyan Hill Publishing) (Ad)tc pixel Free MRM Stock Alerts

Medirom Healthcare Technologies (MRM) Competitors

Medirom Healthcare Technologies logo
$0.99 +0.03 (+3.33%)
As of 03:50 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

MRM vs. COE, SDA, BSAA, BODI, and RGS

Should you buy Medirom Healthcare Technologies stock or one of its competitors? Medirom Healthcare Technologies's main competitors and comparable companies include 51Talk Online Education Group (COE), SunCar Technology Group (SDA), BEST SPAC I Acquisition (BSAA), Beachbody (BODI), and Regis (RGS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "diversified consumer services" industry.

How does Medirom Healthcare Technologies compare to 51Talk Online Education Group?

51Talk Online Education Group (NYSE:COE) and Medirom Healthcare Technologies (NASDAQ:MRM) are both small-cap consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
51Talk Online Education Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Medirom Healthcare Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Medirom Healthcare Technologies has a net margin of 0.00% compared to 51Talk Online Education Group's net margin of -24.26%.

Company Net Margins Return on Equity Return on Assets
51Talk Online Education Group-24.26% N/A -30.40%
Medirom Healthcare Technologies N/A N/A N/A

51Talk Online Education Group has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market. Comparatively, Medirom Healthcare Technologies has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market.

In the previous week, 51Talk Online Education Group's average media sentiment score of 0.00 equaled Medirom Healthcare Technologies'average media sentiment score.

Company Overall Sentiment
51Talk Online Education Group Neutral
Medirom Healthcare Technologies Neutral

Medirom Healthcare Technologies has lower revenue, but higher earnings than 51Talk Online Education Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
51Talk Online Education Group$108.54M1.09-$15.03M-$2.79N/A
Medirom Healthcare Technologies$54.89M0.51$980KN/AN/A

Summary

Medirom Healthcare Technologies beats 51Talk Online Education Group on 5 of the 7 factors compared between the two stocks.

How does Medirom Healthcare Technologies compare to SunCar Technology Group?

SunCar Technology Group (NASDAQ:SDA) and Medirom Healthcare Technologies (NASDAQ:MRM) are both small-cap consumer discretionary companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

SunCar Technology Group has a net margin of 0.04% compared to Medirom Healthcare Technologies' net margin of 0.00%. SunCar Technology Group's return on equity of 0.21% beat Medirom Healthcare Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
SunCar Technology Group0.04% 0.21% 0.07%
Medirom Healthcare Technologies N/A N/A N/A

In the previous week, SunCar Technology Group had 1 more articles in the media than Medirom Healthcare Technologies. MarketBeat recorded 1 mentions for SunCar Technology Group and 0 mentions for Medirom Healthcare Technologies. Medirom Healthcare Technologies' average media sentiment score of 0.00 beat SunCar Technology Group's score of -0.35 indicating that Medirom Healthcare Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
SunCar Technology Group Neutral
Medirom Healthcare Technologies Neutral

SunCar Technology Group presently has a consensus target price of $5.00, indicating a potential upside of 525.16%. Given SunCar Technology Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe SunCar Technology Group is more favorable than Medirom Healthcare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SunCar Technology Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Medirom Healthcare Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

0.3% of SunCar Technology Group shares are owned by institutional investors. 22.2% of SunCar Technology Group shares are owned by company insiders. Comparatively, 40.2% of Medirom Healthcare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Medirom Healthcare Technologies has lower revenue, but higher earnings than SunCar Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SunCar Technology Group$489.29M0.17-$3.94MN/AN/A
Medirom Healthcare Technologies$54.89M0.51$980KN/AN/A

SunCar Technology Group has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market. Comparatively, Medirom Healthcare Technologies has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market.

Summary

SunCar Technology Group beats Medirom Healthcare Technologies on 9 of the 14 factors compared between the two stocks.

How does Medirom Healthcare Technologies compare to BEST SPAC I Acquisition?

Medirom Healthcare Technologies (NASDAQ:MRM) and BEST SPAC I Acquisition (NASDAQ:BSAA) are both small-cap consumer discretionary companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medirom Healthcare Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
BEST SPAC I Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Medirom Healthcare Technologies has higher revenue and earnings than BEST SPAC I Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medirom Healthcare Technologies$54.89M0.51$980KN/AN/A
BEST SPAC I AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Medirom Healthcare TechnologiesN/A N/A N/A
BEST SPAC I Acquisition N/A N/A N/A

In the previous week, BEST SPAC I Acquisition had 1 more articles in the media than Medirom Healthcare Technologies. MarketBeat recorded 1 mentions for BEST SPAC I Acquisition and 0 mentions for Medirom Healthcare Technologies. BEST SPAC I Acquisition's average media sentiment score of 1.71 beat Medirom Healthcare Technologies' score of 0.00 indicating that BEST SPAC I Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
Medirom Healthcare Technologies Neutral
BEST SPAC I Acquisition Very Positive

Summary

BEST SPAC I Acquisition beats Medirom Healthcare Technologies on 2 of the 3 factors compared between the two stocks.

How does Medirom Healthcare Technologies compare to Beachbody?

Medirom Healthcare Technologies (NASDAQ:MRM) and Beachbody (NASDAQ:BODI) are both small-cap consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Beachbody has a consensus target price of $15.67, suggesting a potential upside of 53.29%. Given Beachbody's stronger consensus rating and higher possible upside, analysts clearly believe Beachbody is more favorable than Medirom Healthcare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medirom Healthcare Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Beachbody
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Medirom Healthcare Technologies has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Beachbody has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market.

Medirom Healthcare Technologies has higher earnings, but lower revenue than Beachbody.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medirom Healthcare Technologies$54.89M0.51$980KN/AN/A
Beachbody$251.73M0.29-$2.86M$0.6715.25

Beachbody has a net margin of 2.21% compared to Medirom Healthcare Technologies' net margin of 0.00%. Beachbody's return on equity of 33.74% beat Medirom Healthcare Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Medirom Healthcare TechnologiesN/A N/A N/A
Beachbody 2.21%33.74%6.40%

In the previous week, Beachbody had 11 more articles in the media than Medirom Healthcare Technologies. MarketBeat recorded 11 mentions for Beachbody and 0 mentions for Medirom Healthcare Technologies. Beachbody's average media sentiment score of 0.31 beat Medirom Healthcare Technologies' score of 0.00 indicating that Beachbody is being referred to more favorably in the news media.

Company Overall Sentiment
Medirom Healthcare Technologies Neutral
Beachbody Neutral

74.5% of Beachbody shares are owned by institutional investors. 40.2% of Medirom Healthcare Technologies shares are owned by company insiders. Comparatively, 42.4% of Beachbody shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Beachbody beats Medirom Healthcare Technologies on 11 of the 14 factors compared between the two stocks.

How does Medirom Healthcare Technologies compare to Regis?

Regis (NASDAQ:RGS) and Medirom Healthcare Technologies (NASDAQ:MRM) are both small-cap consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Regis has a net margin of 52.01% compared to Medirom Healthcare Technologies' net margin of 0.00%. Regis' return on equity of 3.60% beat Medirom Healthcare Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Regis52.01% 3.60% 1.16%
Medirom Healthcare Technologies N/A N/A N/A

Regis has higher revenue and earnings than Medirom Healthcare Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Regis$210.13M0.34$123.54M$43.490.65
Medirom Healthcare Technologies$54.89M0.51$980KN/AN/A

Regis has a beta of 1.37, meaning that its share price is 37% more volatile than the broader market. Comparatively, Medirom Healthcare Technologies has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market.

31.5% of Regis shares are held by institutional investors. 4.8% of Regis shares are held by insiders. Comparatively, 40.2% of Medirom Healthcare Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Regis currently has a consensus target price of $42.00, suggesting a potential upside of 48.27%. Given Regis' stronger consensus rating and higher probable upside, analysts plainly believe Regis is more favorable than Medirom Healthcare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Regis
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Medirom Healthcare Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Regis had 2 more articles in the media than Medirom Healthcare Technologies. MarketBeat recorded 2 mentions for Regis and 0 mentions for Medirom Healthcare Technologies. Regis' average media sentiment score of 0.34 beat Medirom Healthcare Technologies' score of 0.00 indicating that Regis is being referred to more favorably in the media.

Company Overall Sentiment
Regis Neutral
Medirom Healthcare Technologies Neutral

Summary

Regis beats Medirom Healthcare Technologies on 12 of the 14 factors compared between the two stocks.

Get Medirom Healthcare Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRM vs. The Competition

Export
MetricMedirom Healthcare TechnologiesDiversified Consumer Services IndustryConsumer Discretionary SectorNASDAQ Exchange
Market Cap$28.16M$4.38B$13.40B$12.95B
Dividend YieldN/A2.80%53.98%10.20%
P/E RatioN/A11.6046.5024.73
Price / Sales0.5119.9791.25108.63
Price / Cash9.4014.8719.3137.44
Price / Book4.313.494.546.42
Net Income$980K$239.91M$443.65M$347.12M
7 Day Performance11.46%0.17%0.61%2.48%
1 Month Performance0.20%-1.41%1.78%-1.04%
1 Year PerformanceN/A-0.51%2.82%23.22%

Medirom Healthcare Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MRM
Medirom Healthcare Technologies
0.4082 of 5 stars		$0.99
+3.3%		N/AN/A$28.16M$54.89MN/A1,051
COE
51Talk Online Education Group
N/A$17.66
+1.3%		N/A-40.6%$105.68M$108.54MN/A620
SDA
SunCar Technology Group
2.6446 of 5 stars		$0.76
-3.2%		$5.00
+560.4%		-61.9%$82.62M$489.29MN/AN/A
BSAA
BEST SPAC I Acquisition
1.4482 of 5 stars		$10.85
+1.8%		N/AN/A$78.88MN/AN/A1
BODI
Beachbody
4.0996 of 5 stars		$9.75
-2.4%		$15.67
+60.7%		+122.8%$72.35M$251.73M14.551,020

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MRM) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Barricks gold output fell from 2 million ounces to 719000
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The ultimate IPO unicorn
Anthropic is now worth more than a trillion dollars, making it the first private company to reach that milesto...
Weiss Ratings | Sponsoredtc pixel
A $5 stock inside Kennedy Space Center?
A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken...
Freedom Financial | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Wall Street owns 88%. You don’t know the name.
Institutions already control 88% of this company's shares. BlackRock holds roughly 32 million shares, Vanguard...
Monument Traders Alliance | Sponsoredtc pixel